PRT17 Targeting the IL-31 Neuroimmune Pathway: A Case-Based Approach
Sun, Mar 29, 10:30 AM - 11:15 AM
Exhibit Hall - Theater 1
Product Theater
DESCRIPTION
This presentation delves into the critical role of neuroimmune interactions in PN and AD, focusing on how targeted IL-31 treatment improves patient outcomes, as demonstrated in real-world cases
Presented by: Galderma